Literature DB >> 10961269

Radiographic contrast media.

H S Thomsen1, S K Morcos.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10961269     DOI： 10.1046/j.1464-410x.2000.00586.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  13 in total

1.  Management of acute adverse reactions to contrast media.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

Review 2.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

3.  Imaging-related medications: a class overview.

Authors:  Jill M Widmark
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-10

Review 4.  Adverse reactions to iodinated contrast media.

Authors:  Wendy Bottinor; Pritam Polkampally; Ion Jovin
Journal:  Int J Angiol       Date:  2013-09

5.  Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice.

Authors:  Rajan K Gupta; Tami J Bang
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

6.  Contrast Media Adverse Drug Reactions in Highly Polluted Environment.

Authors:  Natalia Sauer; Wojciech Szlasa; Laura Jonderko; Krystyna Głowacka; Katarzyna Karłowicz-Bodalska; Anna Wiela-Hojeńska
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

7.  Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction.

Authors:  Chao-Fu Chang; Xiao-Ming Liu; Kelly J Peyton; William Durante
Journal:  Biochem Pharmacol       Date:  2013-11-15       Impact factor: 5.858

8.  Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.

Authors:  Vivekanandan Kalaiselvan; Surbhi Sharma; Gyanendra Nath Singh
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

9.  Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model.

Authors:  Altaf-M Khan; Jerome L Maderdrut; Min Li; Herman L Toliver; David H Coy; Eric E Simon; Vecihi Batuman
Journal:  Physiol Rep       Date:  2013-11-19

10.  The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM).

Authors:  Jai-Sing Yang; Yan-Ru Peng; Shih-Chang Tsai; Yeu-Sheng Tyan; Chi-Cheng Lu; Hong-Yi Chiu; Yu-Jen Chiu; Sheng-Chu Kuo; Yuh-Feng Tsai; Ping-Chin Lin; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.